tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AGIO Stock Latest News

Positive Developments and Strategic Partnerships Bolster Agios Pharma’s Buy Rating
RatingsPositive Developments and Strategic Partnerships Bolster Agios Pharma’s Buy Rating
1d ago
AGIO
Agios Pharmaceuticals receives positive CHMP opinion for PYRUKYND
PremiumThe Fly
Agios Pharmaceuticals receives positive CHMP opinion for PYRUKYND
2d ago
AGIO
Agios Pharmaceuticals falls -13.3%
PremiumThe Fly
Agios Pharmaceuticals falls -13.3%
1M ago
AGIO
H.C. Wainwright still confident in approval of Agios’ Pyrukynd despite delay
PremiumThe Fly
H.C. Wainwright still confident in approval of Agios’ Pyrukynd despite delay
1M ago
AGIO
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
PremiumThe Fly
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
1M ago
AGIO
Agios Pharmaceuticals falls -14.4%
PremiumThe FlyAgios Pharmaceuticals falls -14.4%
1M ago
AGIO
Agios Pharmaceuticals provides update on U.S. PDUFA goal date for PYRUKYND
Premium
The Fly
Agios Pharmaceuticals provides update on U.S. PDUFA goal date for PYRUKYND
1M ago
AGIO
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
Premium
Ratings
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
2M ago
AGIO
Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
PremiumThe Fly
Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
3M ago
AGIO
Agios Pharma’s PYRUKYND Approved by Saudi Authority
PremiumCompany Announcements
Agios Pharma’s PYRUKYND Approved by Saudi Authority
3M ago
8K
AGIO
Leerink says Agios pressure related to deaths listed in FAERS database
PremiumThe Fly
Leerink says Agios pressure related to deaths listed in FAERS database
3M ago
AGIO
Agios evaluating fourth Pyrukynd case after analyst report
PremiumThe Fly
Agios evaluating fourth Pyrukynd case after analyst report
3M ago
AGIO
Agios Pharmaceuticals falls -17.8%
PremiumThe FlyAgios Pharmaceuticals falls -17.8%
3M ago
AGIO
Agios Pharmaceuticals falls -22.9%
Premium
The Fly
Agios Pharmaceuticals falls -22.9%
3M ago
AGIO
Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
3M ago
AGIO
Agios Pharma’s Promising Growth: Buy Rating Backed by Strong Drug Performance and Strategic Focus
PremiumRatings
Agios Pharma’s Promising Growth: Buy Rating Backed by Strong Drug Performance and Strategic Focus
3M ago
AGIO
Agios Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
Agios Pharmaceuticals Reports Q2 2025 Financial Results
3M ago
AGIO
Agios Pharma’s Strong Market Performance and Strategic Growth Prospects Drive Buy Rating
PremiumRatings
Agios Pharma’s Strong Market Performance and Strategic Growth Prospects Drive Buy Rating
3M ago
AGIO
Agios Pharma’s Strategic Launch Preparations for Mitapivat and International Expansion
PremiumRatings
Agios Pharma’s Strategic Launch Preparations for Mitapivat and International Expansion
3M ago
AGIO
Agios Pharmaceuticals reports Q2 EPS ($1.93) , consensus ($1.75)
PremiumThe FlyAgios Pharmaceuticals reports Q2 EPS ($1.93) , consensus ($1.75)
3M ago
AGIO
Agios Pharmaceuticals price target lowered to $65 from $71 at Scotiabank
Premium
The Fly
Agios Pharmaceuticals price target lowered to $65 from $71 at Scotiabank
3M ago
AGIO
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
Premium
The Fly
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
3M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >